Albireo Pharma Profit Margin 2007-2021 | ALBO
Current and historical gross margin, operating margin and net profit margin for Albireo Pharma (ALBO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Albireo Pharma net profit margin as of June 30, 2021 is -1468.41%.
|Albireo Pharma Annual Profit Margins
|Albireo Pharma Quarterly Profit Margins
||Medical - Biomedical and Genetics
Albireo Pharma, Inc. is a biopharmaceutical company. It focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo Pharma Inc., formerly known as BIODEL INC., is based in Boston, United States.